Harvard Bioscience appoints Jeff Duchemin as the new CEO
– USA, MA – Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that its Board of Directors has hired Jeffrey A.…